Brandon Capital

Brandon Capital is Australasia's leading life-sciences venture capital firm, based in Melbourne and founded in 2006 by Chris Nave. It invests in early-stage biomedical and pharmaceutical companies through its BioCatalyst funds, the sixth of which closed at over A$439 million in July 2025.